Literature DB >> 2542048

1-Aminocyclobutane-1-carboxylate (ACBC): a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor.

W F Hood1, E T Sun, R P Compton, J B Monahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2542048     DOI： 10.1016/0014-2999(89)90861-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

Review 2.  A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.

Authors:  P L Wood; T S Rao; S Iyengar; T Lanthorn; J Monahan; A Cordi; E Sun; M Vazquez; N Gray; P Contreras
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: antagonism at the strychnine-insensitive glycine receptor.

Authors:  N Hershkowitz; M A Rogawski
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

4.  Selective Vulnerabilities of N-methyl-D-aspartate (NMDA) Receptors During Brain Aging.

Authors:  Kathy R Magnusson; Brenna L Brim; Siba R Das
Journal:  Front Aging Neurosci       Date:  2010-03-19       Impact factor: 5.750

5.  Molecular electrostatic potentials in aromatic substituted 4-hydroxyquino-2-lones: glycine/NMDA receptor antagonists.

Authors:  Kaustubh A Joshi; Dinannath D Patil; Shridhar P Gejji
Journal:  J Mol Model       Date:  2008-12-09       Impact factor: 1.810

Review 6.  The NMDA receptor as a target for cognitive enhancement.

Authors:  Graham L Collingridge; Arturas Volianskis; Neil Bannister; Grace France; Lydia Hanna; Marion Mercier; Patrick Tidball; Guangyu Fang; Mark W Irvine; Blaise M Costa; Daniel T Monaghan; Zuner A Bortolotto; Elek Molnár; David Lodge; David E Jane
Journal:  Neuropharmacology       Date:  2012-07-11       Impact factor: 5.250
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.